MedTrace Logo

Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance

NCT06107088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2024-07-16

No results posted yet for this study

Summary

The goal of this clinical trial is to test whether a new combination of lactase and bacterial strain (L. Salivarius DSM 34078) can provide longer lasting beneficial effects on lactose digestion and gastrointestinal symptoms compared to lactase alone in people with lactose intolerance.

Conditions

  • Lactose Intolerance

Interventions

DIETARY_SUPPLEMENT

Active 1

lactase enzyme

DIETARY_SUPPLEMENT

Active 2

lactase-bacterial strain combination

DIETARY_SUPPLEMENT

Active 3

bacterial strain alone

DIETARY_SUPPLEMENT

Placebo

placebo

Sponsors & Collaborators

  • Analyze & Realize

    collaborator NETWORK

  • Novozymes A/S

    lead INDUSTRY

Principal Investigators

  • Liana Vismane, MD · analyze & realize GmbH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2024-07-10
Completion
2024-07-10

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06107088 on ClinicalTrials.gov